Related content

Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes

By                                    

International Journal of Oncology, Vol. 40, Iss. 1, 2012-01 ,pp. : 63-70

Spandidos Publications

Access to resources Recommend Favorite

Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide

By              

International Journal of Oncology, Vol. 42, Iss. 3, 2013-01 ,pp. : 831-838

Spandidos Publications

Access to resources Recommend Favorite

WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval

By Saitoh Anri  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 219-230

Humana Press, Inc

Access to resources Recommend Favorite

Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 6, 2011-07 ,pp. : 543-548

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line

By Santegoets Saskia   Schreurs Marco   Masterson Allan   Liu Ying   Goletz Steffen   Baumeister Hans   Kueter Esther   Lougheed Sinéad   Eertwegh Alfons   Scheper Rik   Hooijberg Erik   Gruijl Tanja  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1480-1490

Springer Publishing Company

Access to resources Recommend Favorite